Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation.

LeukemiaĀ·2019
Same author

Forkhead box O transcription factors in chondrocytes regulate endochondral bone formation.

The Journal of steroid biochemistry and molecular biologyĀ·2015
Same author

Generation and maintenance of hybridomas.

Immunology todayĀ·2014
Same author

The production of more useful monoclonal antibodies I. Modifications of the basic technology.

Immunology todayĀ·2014
Same author

The production of more useful monoclonal antibodies 2. The use of somatic-cell genetic and recombinant-DNA technology to tailor-make monoclonal antibodies.

Immunology todayĀ·2014
Same author

The MutSĪ² complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair.

OncogeneĀ·2013

Related Experiment Video

Updated: May 5, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

39.4K

Tailor-made monoclonal antibodies.

R A DePinho, L B Feldman, M D Scharff

    Annals of Internal Medicine
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Monoclonal antibodies are vital research tools, but challenges remain. This review explores antibody biology and genetics to guide the development of more effective diagnostic and therapeutic monoclonal antibodies.

    More Related Videos

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
    13:14

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

    Published on: February 6, 2018

    10.0K
    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
    07:36

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

    Published on: May 16, 2020

    4.9K

    Related Experiment Videos

    Last Updated: May 5, 2026

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology
    09:42

    Generation of Murine Monoclonal Antibodies by Hybridoma Technology

    Published on: January 2, 2017

    39.4K
    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
    13:14

    Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

    Published on: February 6, 2018

    10.0K
    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
    07:36

    Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

    Published on: May 16, 2020

    4.9K

    Area of Science:

    • Immunology
    • Molecular Biology
    • Biotechnology

    Background:

    • Monoclonal antibodies (mAbs) are indispensable reagents in basic and clinical research, offering significant diagnostic and therapeutic potential.
    • Despite their impact, several challenges hinder the full realization of mAb technology.
    • Understanding the fundamental biology and genetic underpinnings of antibodies is crucial for progress.

    Purpose of the Study:

    • To review the basic biology of antibody molecules.
    • To discuss the genes encoding antibody molecules.
    • To explore how this knowledge can be leveraged for developing more effective monoclonal antibodies.

    Main Methods:

    • Literature review focusing on antibody structure and function.
    • Analysis of genetic mechanisms underlying antibody production.
    • Discussion of strategies for enhancing mAb efficacy based on biological insights.

    Main Results:

    • Antibody molecules possess complex structures and functions critical for their biological roles.
    • The genes encoding antibodies exhibit unique diversity-generating mechanisms.
    • Knowledge of antibody biology and genetics provides a foundation for engineering improved mAbs.

    Conclusions:

    • Addressing current limitations in mAb technology requires a deep understanding of antibody molecular biology and genetics.
    • Applying this knowledge can lead to the development of superior diagnostic and therapeutic monoclonal antibodies.
    • Further research into antibody engineering holds promise for advancing biomedical applications.